Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Cederling Naprapati & Hälsa AB
AB
Dissolved
Org 5593723082
Falun
Other human health activities · NACE 8690
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2023
SEK 14K
-41% vs 2022
EBITDA margin
-60.4%
-484% vs 2022
Equity ratio
100.0%
Financial strength
Net profit 2023
SEK -8K
-475% vs 2022
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
Key figures
Annual report 2023
Revenue
SEK 14K
-41%
EBITDA
SEK -9K
-484%
Net profit
SEK -8K
-475%
Total assets
SEK 15K
-57%
Equity
SEK 15K
-35%
Employees
1
—
Company information
Legal name
Cederling Naprapati & Hälsa AB
Org number
5593723082
Legal form
Aktiebolag
NACE code
8690 · Other human health activities
Founded
24 mars 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Företaget ska bedriva behandlingar i olika former som ska främja människors fysiska hälsa.
Contact
Address
Falun
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other human health activities
Companies in Solna
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
Income statement
SEK thousands
Item
2022
2023
Revenue
24
14
Staff expenses
−1
−4
EBITDA
−1
−9
Depreciation & amort.
—
—
EBIT
−1
−9
Net financials
0
0
Profit before tax
−1
−8
Tax
—
—
Net profit
−1
−8
Balance sheet
SEK thousands
Item
2022
2023
Total assets
36
15
Equity
24
15
Long-term debt
—
—
Short-term debt
12
0
Total debt
12
—
Financial ratios
5-year trend
EBITDA margin
-60.4%
This company
15.8%
Market median
-482% vs market
2022
2023
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2022
2023
Return on equity
-54.5%
This company
18.4%
Market median
-396% vs market
2022
2023
Net profit margin
-58.2%
This company
8.1%
Market median
-819% vs market
2022
2023
Asset turnover
0.94×
This company
1.12×
Market median
+16% vs market
2022
2023
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2022
2023
Annual reports & filings
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-03-24 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
LB
Lena Birgitta Killgren Jonsson
Deputy Board Member
2025
IM
Inger Margareta Dahle
Deputy Board Member
2025
BJ
Bengt Junior Niklas Nygårds
Board of Directors
2025
PE
Per Erik Wennerström
Deputy Board Member
2025
Former (2)
OT
Oskar Thomas Cederling
Board of Directors
2022 – 2025
GL
Gerd Liselotte Cederling
Deputy Board Member
2022 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Cederling Naprapati & Hälsa AB also hold positions in
0
other companies.
Person
Role here
Other companies
Lena Birgitta Killgren Jonsson
Deputy Board Member
0 companies
Inger Margareta Dahle
Deputy Board Member
0 companies
Bengt Junior Niklas Nygårds
Board of Directors
0 companies
Oskar Thomas Cederling
Board of Directors
0 companies
Gerd Liselotte Cederling
Deputy Board Member
0 companies
Per Erik Wennerström
Deputy Board Member
0 companies